Tumor oxygenation after hyperthermia in the rat 13762 mammary carcinoma and the DU-145 human prostate carcinoma

International Journal of Oncology

Volumn 10, Issue 3, 1997, Pages 437-442

  Teicher, Beverly A ^a   Ara, Gulshan ^a   Takeuchi, Hideya ^a   Coleman, C Norman ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

13762 mammary carcinoma; DU 145 prostate carcinoma; hyperthermia; tumor oxygenation

Indexed keywords

CARBOGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BREAST CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPERTHERMIA; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; PROSTATE CARCINOMA; RAT; REVIEW; TUMOR XENOGRAFT;

EID: 0030984234     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.10.3.437     Document Type: Review

References (55)

1. Teicher BA: Hypoxia and drug resistance. In: Cancer and Metastasis Reviews. Frost P, Hart I and Kerbel R (eds). Kluwer Academic Publishers, Dordrecht, pp139-168, 1994.
2. Teicher BA, Dupuis NP, Holden SA, Schwartz GN, Lester S and Frei E III: Definition and manipulation of tumor oxygenation. Radiat Oncol Invest 2: 66-76, 1994.
3. Teicher BA: Physiologic mechanisms of therapeutic resistance: blood flow and hypoxia. In: Hematology/Oncology Clinics of North America. Drug Resistance in Clinical Oncology and Hematology. Fisher G (ed). W.B. Saunders Co, Philadelphia, pp475-506, 1995.
4. Overgaard J: The current and potential role of hyperthermia in radiotherapy. Int J Radiat Oncol Biol Phys 16: 535-549, 1989.
5. Overgaard J: Rationale and problems in the design of clinical studies. In: Hyperthermia Oncology. Overgaard J (ed). Taylor and Francis, London, pp325-338, 1985.
6. Overgaard J, Gonzalez D, Hulshor M, Archangelli G, Dahl O, Mella O and Bentzen S: Randomized trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet 345: 540-543, 1995.
7. International Consensus Meeting on Hyperthermia, Final Report. Int J Hyperthermia 6: 837, 1990.
8. Herman TS, Teicher BA, Holden SA and Collins LC: Interaction of hyperthermia and radiation in murine cells: hypoxia and acidosis in vitro, tumor subpopulations in vivo. Cancer Res 49: 3338-3343, 1989.
9. Vaupel P, Frinak S and Bicher HI: Heterogeneous oxygen partial pressure and pH distribution C3H mouse mammary adenocarcinoma. Cancer Res 41: 2008-2013, 1981.
10. Vaupel P, Fortmeyer HP, Runkel S and Kallinowski F: Blood flow, oxygen consumption and tissue oxygenation of human breast cancer xenografts in athymic rats. Cancer Res 47: 3496-3503, 1987.
11. 2 and radiosensitivity of tumors by Fluosol-DA (20%) and carbogen. Cancer Res 47: 442-446, 1987.
12. 2 by perfluorochemicals and carbogen. Int J Radiat Oncol Biol Phys 13: 569-574, 1987.
13. Kennedy KA, Teicher BA, Rockwell SA and Sartorelli AC: Chemotherapeutic approaches to cell populations in tumors. Bristol-Myers Cancer Symposia (ed). Academic Press, New York, pp85-101, 1981.
14. Guillino P: In vivo utilization of oxygen and glucose by neoplastic tissue. Adv Exp Mcd Biol 75: 521-536, 1975.
15. Momparler RL: In vitro systems for evaluation of combination chemotherapy. Pharmacol Ther Part A Chemother Toxicol Metab Inhibitors 8: 21-35, 1980.
16. Born R, Hug O and Trott KR: The effect of prolonged hypoxia on growth and viability of Chinese hamster ovary cells. Int J Radiat Oncol Biol Phys 1: 687-697, 1976.
17. Gray L, Conger A, Ebert M, Hornsey S and Scott O: The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 26: 638-648, 1953.
18. Sartorelli AC: Therapeutic attack of hypoxic cells of solid tumors: presidential address. Cancer Res 48: 775-778, 1988.
19. Keyes S, Heimbrook D, Fracasso P, Rockwell S, Sugar S and Sartorelli A: Chemotherapeutic attack of hypoxic tumor cells by the bioreductive alkylating agent mitomycin C. Adv Enzyme Regul 23: 291-307, 1985.
20. Kennedy KA, Teicher BA, Rockwell SA and Sartorelli AC: The hypoxic tumor cell: a target for selective cancer chemotherapy. Biochem Pharmacol 29: 1-8, 1980.
21. Teicher BA, Lazo JS and Sartorelli AC: Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res 41: 73-81, 1981.
22. Gerweek LE: Effect of microenvironmental factors on response of cells to single and fractionated heat treatments. NCI Monograph 61: 19-26, 1982.
23. Bichel P and Overgaard J: Hyperthermic effect on exponential and plateau ascites tumor cells in vitro dependent on environmental pH. Radiat Res 70: 449-454, 1977.
24. Rottingcr E, Mendonca M and Gerweek L: Modification of pH induced cellular inactivation by irradiation: glial cells. Int J Radiat Oncol Biol Phys 6: 1659-1662, 1980.
25. Holahan E, Stuart P and Dewey W: Enhancement of survival of CHO cells by acidic pH after X-irradiation. Radiat Res 89: 433-435, 1982.
26. Holahan E, Highfield D, Holahan P and Dewey W: Hyperthermic killing and hyperthermic radiosensitization in Chinese hamster ovary cells: effects pH and thermal tolerance. Radiat Res 97: 108-131, 1984.
27. Chu G and Dewey W: The role of low intracellular or extracellular pH in sensitization to hyperthermia. Radiat Res 114: 154-167, 1988.
28. Leith J, Miller R, Gerner E and Boone M: Hyperthermic potentiation: biological aspects and applications to radiation therapy. Cancer 39: 766-779, 1977.
29. Hall E and Rozin-Towle L: Biological effects of heat. Cancer Res 44: 47085-47135, 1984.
30. Suit H and Gerwick L: Potential for hyperthermia and radiation therapy. Cancer Res 39: 2290-2298, 1979.
31. Leeper D: Adjuvant hyperthermia in radiation therapy. Head Neck Cancer 1: 338-345, 1985.
32. Perez C, Kuski R, Emami B and Fineberg B: Irradiation alone or combined with hyperthermia in the treatment of recurrent carcinoma of the breast in the chest wall: a non-randomized comparison. Int J Hyperthermia 2: 179-182, 1986.
33. Kapp D, Bagshaw M, Meyer J, Hahn G, Samulski T, Fessenden P, Lee E and Lohrbach A: Hyperthermia as an adjuvant to radiation in the the treatment of superficial metastases: a randomized trial of 2 versus 6 heat treatments. In: Proceedings of the 34th Annual Meeting of the Radiation Research Society, (ed). p24, 1986.
34. Herman TS, Teicher BA, Jochelson M, Clark J, Svensson G and Coleman CN: Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignancies. Int J Hyperthermia 4: 143-158, 1988.
35. Oleson J: Hyperthermia from the clinic to the laboratory: a hypothesis. Int J Hyperthermia 11: 315-322, 1995.
36. Teicher BA, Dupuis NP, Robinson MF, Kusumoto T, Liu M and Menon K: Reduced oxygenation in a rat mammary carcinoma post-radiation and reoxygenation with a perflubron emulsion/carbogen breathing. In Vivo 8: 125-132, 1994.
37. Teicher BA, Dupuis NP, Kusumoto T, Liu M, Liu F, Menon K, Schwartz GN and Frei E III: Decreased tumor oxygenation after cyclophosphamide reoxygenation and therapeutic enhancement with a perflubron emulsion/carbogen breathing. Int J Oncol 3: 197-203, 1993.
38. Teicher BA, Holden SA, Ara G, Dupuis N and Goff D; Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing. Cancer J Sci Am 1: 43-48, 1995.
39. Kakeji Y, Machara Y, Ikebe M and Teicher B: Dynamics of tumor oxygenation, CD31 staining and transforming growth factor-β levels after treatment with radiation or cyclophosphamide in the rat 13762 mammary carcinoma. Int J Rad Oncol Biol Phys (In press).
40. Teicher B, Bump E, Palayoor S, Northey D and Coleman C: Signal transduction inhibitors as modifiers of radition therapy in hman prostate carcinoma xenografts. Rad Oncol Invst (In press).
41. Herman TS and Teicher BA: Summary of studies adding systemic chemotherapy to local hyperthermia and radiation. Int J Hyperthermia 10: 443-449, 1994.
42. Herman TS and Teicher BA: Sequencing of trimodality therapy [cis-diamminedichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSallC fibrosarcoma. Cancer Res 48: 2693-2697, 1988.
43. Kang M, Rhee J, Levitt S and Wong C: Cytocidal effect of hyperthermia on tumor cells in vivo. Natl Cancer Inst Monogr 61: 157-159, 1982.
44. Marmae J, Hilerio J and Hahn G: Tumor erradication and cell survival after localized hyperthermia induced by ultrasound. Cancer Res 39: 2166-2171, 1979.
45. Dickson J and Shah S: Hyperthermia: the immune response and tumor metastasis. Natl Cancer Inst Monogr 61: 183-192, 1982.
46. Koch C, Evans S and Lord E: Comment on the hypothesis that hyperthemia facilitates reoxygenation. Int J Hyperthermia 11: 447-450, 1995.
47. Song C, Shakil A, Osborn J and Iwata K: Tumour oxygenation is increased by hyperthermia at mild temperatures. Int J Hyperthermia 12: 367-373, 1996.
48. Armour E, Wang Z, Cony P and Martinez A: Sensitization of the Rat 9L gliosarcoma cells to low dose irradiation by long duration 41°C hyperthermia. Cancer Res 51: 3088-3095, 1991.
49. Dewey W: Arrhenius relationships from the molecule and cell to clinic. Int J Hyperthermia 10: 457-483, 1994.
50. Mackey M, Anolik S and Roti J: Changes in heat and radiation sensitivity during long duration, moderate hyperthermia in HeLa S3 cells. Int J Radiat Oncol Biol Phys 24: 543-550, 1992.
51. Valdagni R and Acmichetti M: Report of long term follow up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients. Int J Radiat Oncol Biol Phys 28: 163-169, 1994.
52. Song CW, Lyons JC and Luo Y: Intra- and extracellular pH in solid tumors: influence on therapeutic response. In: Drug Resistance in Oncology. Teicher BA (ed). Marcel Dekker, New York, pp25-51, 1992.
53. Lee I, Boucher Y and Jain R: Nicotinamide can lower tumour interstitial fluid pressure: mechanistic and therapeutic implications. Cancer Res 52: 3237-3240, 1992.
54. 4(Neutral Red)2. Cancer Res 50: 3826-3831, 1990.
55. Streffer C: Aspects of biochemical effects of hyperthermia. Natl Cancer Inst Monogr 61: 11-17, 1982.